The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Turtle Cameron since year 2005.
The trader's CIK number is 1758363.
At the time of the last reporting, Turtle Cameron was the Chief Business Officer of Eidos Therapeutics, Inc. .
(stock ticker symbol EIDX).
See this page for all insider trading activities at Eidos Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-11-20||EIDX||Eidos Therapeutics, Inc.||Sale||10,000||55.95||559,510|
|2019-09-04||EIDX||Eidos Therapeutics, Inc.||Sale||5,000||41.80||209,000|
|2019-07-01||BBIO||Bridgebio Pharma, Inc.||Option Ex||12,630||.00||0|
|2019-06-04||EIDX||Eidos Therapeutics, Inc.||Sale||10,000||31.80||318,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Turtle Cameron (Chief Business Officer of Eidos Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.